Ultrastructural alterations in Trypanosoma (Schizotrypanum) cruzi induced by Δ(24(25)) sterol methyl transferase inhibitors and their combinations with ketoconazole

International Journal of Antimicrobial Agents

Volumn 7, Issue 4, 1996, Pages 235-240

  Vivas, Julio ^a,b   Urbina, Julio A ^b   De Souza, Wanderley ^c  

^a FACULTAD DE CIENCIAS   (Venezuela)

^b INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

(24(25)) sterol methyl transferase; sterol biosynthesis inhibitors; Trypanosoma cruzi; ultrastructural alterations

Indexed keywords

ANTITRYPANOSOMAL AGENT; KETOCONAZOLE; STEROL; STEROL DERIVATIVE;

ARTICLE; CELL VACUOLE; CHROMATIN STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; EPIMASTIGOTE; KINETOPLAST; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; STEROL SYNTHESIS; TRYPANOSOMA CRUZI; ULTRASTRUCTURE;

EID: 0030266338     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(96)00325-1     Document Type: Article

References (22)

1. [1] Larralde G, Vivas J, Urbina JA. Concentration and time dependence of the effects of ketoconazole on growth and sterol biosynthesis in Trypanosoma (Schizotrypanum) cruzi epimastigotes. Acta Gient Venez, 1988;39:140-146.
2. [2] Urbina JA, Lazardi K, Aguirre T, Piras MM, Piras R. Antiproliferative synergism of the allylamine SF-86327 and ketoconazole on epimastigotes and amastigotes of Trypansoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother, 1988;32:1237-1242.
3. [3] Urbina JA, Lazardi K, Aguirre T, Piras MM, Piras R. Antiproliferative effects and mechanism of action of ICI 195739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotypanum) cruzi. Antimicrob Agents Chemother, 1991;35:730-735.
4. [4] Lazardi K, Urbina JA, DeSouza W. Ultrastructural alterations induced by ICI 195739, a bis triazole with strong anti-proliferative action against Trypanosma (Schizotrypanum) cruzi. Antimicrob Agents Chemother, 1991;35:736-740.
5. [5] Urbina JA, Lazardi K, Marchan E et al. Mevinolin (lovastatin) potentiates the anti-proliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vivo and in vitro studies. Antimicrob Agents Chemother, 1993;37:580-591.
6. [6] Maldonado RA, Molina J, Payares G, Urbina JA. Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas disease. Antimicrob Agents Chemother, 1993;37:1353-1359.
7. [7] Lazardi K, Urbina JA, DeSouza W. Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother, 1990;34:2097-2105.
8. [8] Urbina JA, Vivas J, Visbal G, Contreras LM. Modification of the sterol composition of Trypanosoma (Schizotrypanum) cruzi epimastigotes by Δ24(25) sterol methyl transferase inhibitors and their combinations with ketoconazole Mol Biochem Parasitol, 1995;79:199-210.
9. 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Chemotherapy, 1996; (in press).
10. [10] Oehlschlager AC, Czyzewska E. Rationally designed inhibitors of sterol biosynthesis. In: Sutcliffe J, Georgopapadakou NH, eds. Emerging Targets in Antibacterial and Antifungal Chemotherapy. New York and London: Chapman and Hall, 1992;437-475.
11. [11] Mercer EI. Inhibitors of sterol biosynthesis and their applications. Prog Lipid Res, 1993;32:357-416.
12. [12] Rahier A, Taton M, Benveniste P. Inhibition of sterol biosynthesis in higher plants by analogues of high energy carbocationic intermediates. In: Kuhn PJ, Trinci APJ, Jung MJ, Goosey MW, Copping LG, eds. Biochemistry of Cell Walls and Membranes in Fungi. Berlin and Heidelberg: Springer Verlag, 1990;205-221.
13. [13] Boyle FT. Drug discovery: a chemist's approach. In: Ryley JF, ed. Chemotherapy of Fungal Infections. Berlin and New York: Springer Verlag, 1990;3-30.
14. [14] Barrett-Bee K, Ryder NS. Biochemical aspects of ergosterol biosynthesis inhibition. In: Sutcliffe J, Georgopapadakou NH, eds. Emerging Targets in Antibacterial and Antifungal Chemotherapy. New York and London: Chapman and Hall, 1992;410-436.
15. 24 methyl transferase. J Med Chem, 1992;35:100-106.
16. [16] Hudson L, Grover F, Gutteridge WE et al. Suggested guidelines for work with live Trypanosoma cruzi. Trans Roy Soc Trop Med Hyg, 1983;77:416-419.
17. [17] De Maio A, Urbina JA. Trypanosoma (Schizotrypanum) cruzi: terminal oxidases in two growth phases in vitro. Acta Cient Venez, 1984;35:136-141.
18. [18] Parish EJ, Nes WD. Synthesis of new epiminoisopentenoids. Synthet Comm, 1988;18:221-226.
19. [19] Vanden Bossche H. Chemotherapy of human fungal infections. In; Lyr H, ed. Modern Selective Fungicides. Properties, Applications, Mechanism of Action. Jena: Gustav Fisher Verlag, 1995;431-484.
20. [20] Vanden Bossche H, Marichal P. Azole antifungals: mode of action. In: Yamaguchi H, Kobayashi GS, Takahashi H, eds. Recent Progress in Antifungal Chemotherapy. New York: Marcel Dekker, 1992;25-40.
21. [21] DeSouza W. Cell Biology of Trypanosoma cruzi. Int Rev Cytol, 1984;86:197-283.
22. [22] Urbina JA, Vivas J, Ramos H, Larralde G, Aguilar Z, Avilan L. Alteration of lipid order profile and permeability of plasma membranes from Trypanosoma cruzi epimastigotes grown in the presence of ketoconazole. Mol Biochem Parasitol, 1988;30:185-196.